What is Amgen's change in AP?

Amgen (AMGN) reported change in AP of $571M in Q1 2026.

How has Amgen's change in AP changed year-over-year?

Amgen's change in AP increased by 14.9% year-over-year, from $497M to $571M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Amgen AMGN Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

PfizerPFE

-$117.25M+54.2%

Regeneron PharmaceuticalsREGN

$107.7M+150%

Nektar TherapeuticsNKTR

-$934K-115%

Rigel PharmaceuticalsRIGL

-$2.71M-540%

Jazz PharmaceuticalsJAZZ

-$21.4M-212%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's change in AP?: Amgen (AMGN) reported change in AP of $571M in Q1 2026.
How has Amgen's change in AP changed year-over-year?: Amgen's change in AP increased by 14.9% year-over-year, from $497M to $571M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.